ProfileGDS5678 / 1439556_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 49% 46% 46% 46% 46% 50% 46% 45% 45% 46% 46% 46% 46% 46% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.2069249
GSM967853U87-EV human glioblastoma xenograft - Control 23.0866246
GSM967854U87-EV human glioblastoma xenograft - Control 33.0841146
GSM967855U87-EV human glioblastoma xenograft - Control 43.0157946
GSM967856U87-EV human glioblastoma xenograft - Control 53.035846
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.2887750
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.1561746
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.0515245
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.0431545
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.0681846
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.0746346
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.0430946
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.0812746
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.0803946